In the News
K&S Secures Key Court Victory in Pharmaceutical Pricing Litigation
July 1, 2026
| Law360

K&S obtains a favorable ruling on behalf of Amgen in a dispute with the state of Colorado over its price cap for the arthritis drug Enbrel.
 
Third-party coverage:

Amgen Wins Order Blocking Colorado's Enbrel Price Cap (Law360)

Explore King & Spalding
a blue and green background
Capabilities
Appellate, Constitutional & Administrative Law
a blue and green background
Capabilities
Life Sciences & Healthcare